Pulse Biosciences, Inc.
$534.8K 72 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
OraPharma, a division of Bausch Health US, LLC
OraPharma, a division of Bausch Health US, LLC reported $539,122.75 across General Payments, Research, and Ownership to 7,610 physicians and teaching hospitals across 7,610 transactions.
- $539.1K Above-median payer
- All-tracks total
- 7,610 Top quartile volume
- Transactions
- 7,610 Top quartile reach
- Recipients
- −$172.1K
- General Payments vs PY2023
OraPharma, a division of Bausch Health US, LLC reported $539,122.75 across all CMS Open Payments tracks (General + Research + Ownership) to 7,610 physicians and teaching hospitals in Program Year 2024 - ranking #744 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $539,122.75, averaging $70.84 per recipient.
How OraPharma, a division of Bausch Health US, LLC's $539.1K all-tracks total breaks down
OraPharma, a division of Bausch Health US, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
D
50/100
Total payments
F
15/100
Transaction volume
C
65/100
Physician reach
C
68/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer orapharma-a-division-of-bausch-health-us-llc OraPharma, a division of Bausch Health US, LLC
$539.1K · #744/1,925 · 0.0% industry · PY2024
- TOT $539.1K
- RANK #744
- SHARE 0.0%
- TXN 7,610
- RCP 7,610
- CAT 4
- GEN $539.1K
- ΔGEN −$172.1K
- TOP1 40.4%
- PY 2024
Volume peers
Nearest volume peer: Pulse Biosciences, Inc. ($534.8K)
OraPharma, a division of Bausch Health US, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
OraPharma, a division of Bausch Health US, LLC's CMS-reported General Payments decreased by $172.1K (−24.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ORAPHARMA, A DIVISION OF BAUSCH HEALTH US, LLCPY2023: ORAPHARMA, A DIVISION OF BAUSCH HEALTH US, LLCPY2024: OraPharma, a division of Bausch Health US, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $711,225.64
- PY2024
- $539,122.75
What the Data Shows for OraPharma, a division of Bausch Health US, LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For OraPharma, a division of Bausch Health US, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Consulting Fee" leads the 4-category general-payment breakdown below at $277.6K (51.5% of General Payments, 38 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 4 types of general payments, OraPharma, a division of Bausch Health US, LLC's largest category was "Consulting Fee" at $277.6K - 51.5% of General Payments.
OraPharma, a division of Bausch Health US, LLC reports 4 general-payment categories - the top three are Consulting Fee (51.5%), Food and Beverage (28.2%), and Compensation for Faculty or Speaker (Medical Education) (15.7%). The remaining 1 category make up 4.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How OraPharma, a division of Bausch Health US, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $277.6K | 38 | 51.5% |
| Food and Beverage | $152.0K | 7,451 | 28.2% |
| Compensation for Faculty or Speaker (Medical Education) | $84.8K | 29 | 15.7% |
| Travel and Lodging | $24.8K | 92 | 4.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $382,536.33 (71.0%) of $539,122.75 in this company's General Payments records across 5,315 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for OraPharma, a division of Bausch Health US, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Ebone Jordan-Ujari
$217,764.64 across 12 reported transactions
- 2
Timothy Donley
$82,301.72 across 94 reported transactions
- 3
Brett Sealove
$63,869.97 across 91 reported transactions
- 4
Miles Madison
$13,950.00 across 3 reported transactions
- 5
Anastasia Talalenko
$4,650.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
OraPharma, a division of Bausch Health US, LLC's spend rank (#744 of 1,925, top 39% by spend) and concentration rank (#751 of 1,838, top 41% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Kedrion Biopharma, Inc. : $96.5K total payments, HHI 2036
- Pharmaceutical Business Consultants Limited : $59.4K total payments, HHI 2034
- ZSFab, Inc. : $34.3K total payments, HHI 2031
- GastroKlenz, Inc. DBA CloudCath : $1.2K total payments, HHI 2028
- 60 Degrees Pharmaceuticals : $5.2K total payments, HHI 2026
- iSchemaView, Inc. : $178.4K total payments, HHI 2026
- OraPharma, a division of Bausch Health US, LLC (this company) : $539.1K total payments, HHI 2014
- Diality Inc. : $1.5K total payments, HHI 2011
- FUJIFILM Corporation : $77.8K total payments, HHI 2008
- Radformation Inc : $1.7K total payments, HHI 2007
- Endolumik, Inc. : $7.8K total payments, HHI 2005
- Ecs Opco 1 LLC : $1.6K total payments, HHI 1973
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as OraPharma, a division of Bausch Health US, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about OraPharma, a division of Bausch Health US, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with OraPharma, a division of Bausch Health US, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Zynex Monitoring Solutions
$546.3K 0 recipients
Compare payment profiles
Dynavax Technologies Corporation
$530.5K 5,747 recipients
Compare payment profiles
Shield Therapeutics Inc
$548.7K 21,623 recipients
Compare payment profiles
OraSure Technologies Inc.
$529.4K 45 recipients
Compare payment profiles
Amaros, Inc.
$551.3K 0 recipients
Compare payment profiles
Put this to use
OraPharma, a division of Bausch Health US, LLC ranks #744 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just OraPharma, a division of Bausch Health US, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.